Multiple sclerosis is an autoimmune condition that affects your central nervous system. The condition causes your immune system to attack the myelin cells, the protective sheaths surrounding your ...

Dr. Stephen Hauser, a Ross resident who is a neurology professor at the University of California at San Francisco, ...

This year’s Breakthrough Prize—popularly known as the “Oscars of Science”—brought the world’s leading scientists together ...

Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

Experimental drug shows promise for advanced MS, delaying disability. Learn how Black Americans may benefit & why clinical ...

Tolebrutinib, a brain-penetrant and bioactive Bruton tyrosine kinase inhibitor that modulates persistent immune activation ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.